Brain positron emission tomography with 2- 18 F-2-deoxi-D-glucose of patients with dystonia and essential tremor detects differences between these disorders

Abstract

We studied patients with dystonia (D) and essential tremor (ET) using positron emission tomography (PET) equipped with Cortex ID software. This allowed PET brain visualisation to be compared to scans of a control group by means of the z-score. The study revealed hypo-metabolism in both D and ET groups, and additionally revealed a difference between these two groups of patients in certain areas of the brain. These two nosological forms overlap in clinical features and are difficult to differentiate. The PET picture may help to provide a differential diagnosis in addition to the biochemical difference in dopamine exchange previously revealed by us in this group of patients.

Keywords

Dystonia essential tremor PET dopamine

Get full access to this article

View all access options for this article.

References

Belenky

Stanzhevsky

Tutin

et al.

PET in dystonia and essential tremor. Meditsinskaya Vizualizatsia 2010; 5: 77–82.

Song

Park

Chung

et al.

Brain SPECT can differentiate between essential tremor and early-stage tremor-dominant Parkinson’s disease. Clin Neurosci 2014; 21: 1533–1537.

Akdemir

Tokçaer

Karakus

et al.

Brain F-FDG PET imaging in the differential diagnosis of parkinsonism. Clin Nucl Med 2014; 39: 220–226.

Brajkovic

Kostic

Sobic-Saranovic

et al.

The utility of FDG-PET in the differential diagnosis of Parkinsonism. Neurol Res 2017; 5: 1–10.

Minoshima

Frey

Koeppe

et al.

Diagnostic approach in Alzheimer’s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995; 36: 1238–1248.

Talairach

Tournoux

. Co-planar stereotaxic atlas of the human brain: 3-dimensional proportional system – an approach to cerebral imaging, New York: Thieme Medical Publishers, 1988.

Chase

Tamminga

Burrows

. Positron emission tomographic studies of regional cerebral glucose metabolism in idiopathic dystonia. Adv Neurol 1988; 50: 237–241.

Galardi

Perani

Grassi

et al.

Basal ganglia and thalamo-cortical hypermetabolism in patients with spasmodic torticollis. Acta Neurol Scand 1996; 94: 172–176.

Trost

Carbon

Edwards

et al.

Primary dystonia: is abnormal functional brain architecture linked to genotype?

Ann Neurol 2002; 52: 853–856.

10.

Gilman

Junck

Young

et al.

Cerebral metabolic activity in idiopathic dystonia studied with positron emission tomography. Adv Neurol 1988; 50: 231–236.

11.

Martin

Stoessl

Palmer

et al.

PET scanning in dystonia. Adv Neurol 1988; 50: 223–229.

12.

Otsuka

Ichiya

Shima

et al.

Increased striatal 18 dopa uptake and normal glucose metabolism in idiopathic dystonia syndrome. J Neurol Sci 1992; 111: 145–149.

13.

Eidelberg

. Regional metabolic covariation in ITD with 18FDG PET. Mov Disord 1992; 2: 297.

14.

Karbe

Holthoff

Rudolf

et al.

Positron emission tomography demonstrates frontal cortex and basal ganglia hypometabolism in dystonia. Neurology 1992; 42: 1540–1544.

15.

Colebatch

Findley

Frackowiak

. Preliminary report: activation of the cerebellum in essential tremor. Lancet 1990; 336: 1028–1030.

16.

Jenkins

Bain

Colebatch

et al.

A positron emission tomography study of essential tremor: evidence for overactivity of cerebellar connections. Ann Neurol 1993; 34: 82–90.

17.

Wills

Jenkins

Thomson

et al.

Red nuclear and cerebellar but no olivary activation associated with essential tremor: a positron emission tomographic study. Ann Neurol 1994; 36: 636–642.

18.

Wills

Jenkins

Thompson

et al.

A positron emission tomography study of cerebral activation associated with essential and writing tremor. Arch Neurol 1995; 52: 299–305.

19.

Yang

Song

et al.

Changes in regional brain glucose metabolism measured with F-18-FDG-PET in essential tremor. Acta Radiol 2015; 56: 482–486.

20.

Sharifi

Nederveen

Booij

et al.

Neuroimaging essentials in essential tremor: a systematic review. Neuroimage Clin 2014; 5: 217–231.

21.

Gerasimou

Costa

Papanastasiou

et al.

SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor.. Is there any correlation with Parkinson’s disease?

Ann Nucl Med 2012; 26: 337–344.

22.

Dellavedova

Giorgetti

Maffioli

et al.

Impact of ¹²³I-ioflupane SPECT in patient management: essential tremor. Clin Nucl Med 2016; 41: 154–155.

23.

Garraux

Phillips

Schrouff

et al.

Multiclass classification of FDGPET scans for the distinction between Parkinson’s disease and atypical parkinsonian syndromes. Neuroimage Clin 2013; 14: 883–893.

24.

Burn

Sawle

Brooks

. Differential diagnosis of Parkinson’s disease, multiple system atrophy, and Steele–Richardson–Olszewski syndrome: discriminant analysis of striatal ¹⁸F-dopa PET data. J Neurol Neurosurg Psychiatry 1994; 57: 278–584.

25.

Fischman

. Role of [F]-dopa-PET imaging in assessing movement disorders. Radiol Clin North Am 2005; 43: 93–106.

26.

Darcourt

Schiazza

Sapin

et al.

F-FDOPA PET for the diagnosis of parkinsonian syndromes. Q J Nucl Med Mol Imaging 2014; 58: 355–365.